Prognosis Aids
Current treatments for myeloma (e.g. steroids, chemotherapy, and bone marrow transplants) vary dramatically in their side effect potential, and thus not ‘over-treating’ is imperative. MyPRS Plus™ supplies the individualized cancer biology of the patient at a molecular level, further aiding in the process of prognosis and the selection of treatment options that best fits the patient.